Position in IRWD
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$579,479
+$564,568 QoQ
Shares Held
165,094
+4804.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $144,698,835 across 36 Drug Manufacturers - Specialty & Generic names. IRWD ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
164,978 | $97,828,654 | |
| 2 | ZTS |
Zoetis Inc.
|
141,537 | $16,731,088 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
318,927 | $7,631,923 | |
| 4 | VTRS |
Viatris Inc
|
422,971 | $5,714,338 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
27,393 | $3,608,753 | |
| 6 | HLN |
Haleon plc
|
217,156 | $2,173,731 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
34,137 | $1,764,541 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
29,052 | $1,721,912 |
All Filings in IRWD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $579,479 | 165,094 | Shares | Defined | 2026-05-01 | |
| 2024-12-31 | $14,911 | 3,366 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $5,941 | 1,442 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $9,747 | 1,495 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $148 | 17 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $2,425 | 212 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $2,590 | 269 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $5,266 | 495 | Shares | Defined | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||